Skip to main content
. 2021 Jul 27;23(7):e23029. doi: 10.2196/23029

Table 3.

Observed means and SDs for the secondary outcome measures at pre- and posttest for the trial conditions.

Measure and condition Measurement occasion

Pretest Posttest 6-month follow-up

Participants, n Value, mean (SD) Participants, n Value, mean (SD) Participants, n Value, mean (SD)
Depression (PHQ-9a)

EFIb + myCompass 2 280 9.82 (2.77) 75 9.00 (5.18) 91 9.34 (5.47)

myCompass 2 alone 285 9.64 (2.70) 84 8.90 (5.12) 108 7.90 (4.68)

Attention control 284 9.49 (2.92) 123 8.52 (4.94) 136 8.24 (5.86)
Anxiety (GAD-7c)

EFI + myCompass 2 280 7.63 (3.42) 75 7.17 (4.49) 91 6.98 (4.56)

myCompass 2 alone 285 7.28 (3.27) 84 6.55 (4.51) 108 5.96 (4.53)

Attention control 284 7.71 (3.37) 123 6.57 (4.46) 136 6.26 (4.85)
General psychological distress (DQ5d)

EFI + myCompass 2 280 14.50 (2.96) 75 13.89 (4.15) 91 13.98 (4.16)e

myCompass 2 alone 285 14.39 (3.07) 81 12.96 (3.74) 105 12.50 (3.95)

Attention control 284 14.42 (2.87) 118 13.11 (3.65) 135 12.82 (4.35)
Acceptability (UTAUTf)

EFI + myCompass 2 280 14.49 (3.18) 75 14.16 (3.93) 91 12.84 (3.99)

myCompass 2 alone 285 14.42 (3.01) 81 14.42 (3.25) 105 13.51 (3.69)

Attention control 284 14.91 (2.87) 118 14.03 (3.29) 135 13.59 (3.97)
Performance expectancy (UTAUT)

EFI + myCompass 2 280 13.53 (2.67) 75 13.48 (3.54) 91 12.54 (3.69)

myCompass 2 alone 285 13.41 (2.67) 81 13.86 (3.33) 105 13.14 (3.51)

Attention control 284 13.89 (2.70) 118 13.64 (3.10) 135 13.00 (3.66)
Effort expectancy (UTAUT)

EFI + myCompass 2 280 10.66 (2.19) 75 10.40 (2.28) 91 10.20 (2.47)

myCompass 2 alone 285 10.67 (2.12) 81 10.30 (2.35) 105 10.12 (2.23)

Attention control 284 10.54 (1.98) 118 10.49 (2.17) 135 10.37 (2.23)
Data security concerns (UTAUT)

EFI + myCompass 2 280 7.48 (1.86) 75 6.97 (1.82) 91 6.82 (2.04)

myCompass 2 alone 285 7.30 (1.96) 81 7.26 (1.99) 105 7.25 (1.93)g

Attention control 284 7.37 (1.85) 118 6.95 (2.07) 135 6.68 (2.16)
Days out of role

EFI + myCompass 2 280 3.04 (4.49) 75 3.81 (5.68) 91 3.52 (5.85)h

myCompass 2 alone 285 4.14 (5.92) 80 3.91 (5.67) 105 3.43 (6.45)

Attention control 284 3.62 (5.65) 118 3.66 (6.43) 135 2.97 (5.87)
Days cut down

EFI + myCompass 2 280 9.01 (8.33) 75 9.19 (8.83) 91 9.12 (9.72)

myCompass 2 alone 285 9.51 (8.65) 80 7.13 (7.32) 105 8.55 (9.05)

Attention control 284 7.60 (7.32) 118 7.31 (8.07) 135 8.33 (9.63)
Quality of life (EUROHIS-QOLi)

EFI + myCompass 2 280 24.19 (5.15) 75 24.24 (6.63)j 91 24.46 (6.22)k

myCompass 2 alone 285 23.57 (5.13) 80 25.15 (5.81) 105 25.40 (6.06)

Attention control 284 24.46 (5.68) 118 24.86 (5.97) 135 25.75 (6.26)
Suicidal ideation (PSFl)

EFI + myCompass 2 280 0.96 (1.21) m 91 0.91 (1.21)

myCompass 2 alone 285 0.95 (1.21) 105 0.76 (1.13)

Attention control 284 0.84 (1.09) 135 0.82 (1.17)

aPHQ-9: Patient Health Questionnaire-9.

bEFI: engagement facilitation intervention.

cGAD-7: Generalized Anxiety Disorder-7 item.

dDQ5: Distress Questionnaire-5.

ePretest to 6-month follow-up versus myCompass 2 alone (P=.03).

fUTAUT: Unified Theory of Acceptance and Use of Technology.

gPretest to 6-month follow-up versus attention control (P=.01).

hPretest to 6-month follow-up versus myCompass 2 alone (P=.04) and versus attention control (P=.03).

iEUROHIS-QOL: European Health Interview Survey Quality of Life 8-item index.

jPretest to posttest versus myCompass 2 alone (P=.02).

kPretest to 6-month follow-up versus myCompass 2 alone (P=.02).

lPSF: Psychiatric Symptom Frequency scale.

mData for the Psychiatric Symptom Frequency scale measures the items over the previous 6 months; Psychiatric Symptom Frequency scale data were collected at pretest and 6-month follow-up only.